Fast Money Recap: Is Apple Inc. (AAPL) Dividend Hike A Good Idea?

Apple Inc. (NASDAQ:AAPL) certainly receives its fair share of coverage throughout the trading day, and then some. Earlier this morning, we broke news that noted analyst Gene Munster, of Piper Jaffray, was lowering his forecast for the next couple quarters. Specifically, Munster thinks that Apple will only bump its dividend from $10.60 to $14, less than what many bulls are hoping for.

Jim Cramer

Jim Cramer was also on CNBC discussing the situation earlier in the day, and at Mr. Market’s close, the “Fast Money” team was talking about what the analyst community thought about Apple Inc. (NASDAQ:AAPL)’s potential income-boost.

Jon Fortt, of CNBC Business News, discussed the thoughts of “a couple of analysts,” mentioning that “they’re muted,” adding (emphasis placed):

I’ve seen some people saying analysts want a 50% hike, even a doubling of the current dividend; people I’m talking to are more in line with Gene Munster over at Piper Jaffray [...] around 32-33%. The reason why is twofold [...] One, two-thirds of Apple’s cash is overseas. They’ll get hit with a big tax if Apple Inc. (NASDAQ:AAPL) tries to bring it back for dividends. The other is precedent. If they hike the dividend by 50% this year, people expect another 50% hike next year. You can always increase the dividend by more in the future, but if you slow down the rate of hikes, it looks bad.

Regarding Apple Inc. (NASDAQ:AAPL)’s move, Fortt asked an important question: “What if Apple does boost it to $3.50 a share, or more than $15 billion a year?”

The newly upped dividend yield “would be in line with Cisco Systems, Inc. (NASDAQ:CSCO), Hewlett-Packard Company (NYSE:HPQ), and Microsoft Corporation (NASDAQ:MSFT), but still less than Intel Corporation (NASDAQ:INTC),” he added.

More importantly, he also pondered: “Would it be the kind of catalyst that would cause the stock to run like last year?”

This is the question that many perma-bulls have already answered themselves, and may be at least one reason why mega-investment funds like David Einhorn’s Greenlight Capital and David Tepper’s Appaloosa Management LP were upping their stakes last quarter (see why it’s important to track hedge fund activity).

Still, Apple Inc. (NASDAQ:AAPL) obviously has its fair share of bears–say that five times fast–and Fortt’s sources think that a Munster-esque hike would NOT satisfy the market’s majority. Host Melissa Lee’s reasoning is sound:

“[...] If you increase the dividend, it opens all of a sudden Apple to become the holding of a dividend fund that needs to see the dividend increases in order to invest in a stock.”

Josh Brown talked about Apple Inc. (NADSAQ:AAPL)’s decision, inferring that not all types of income boosts are indicative of an attractive company from an investment standpoint, saying ”Talk to an Intel shareholder, and ask him how he likes his 3% dividend.”

SkyBridge Capital founder Anthony Scaramucci had a similar opinion:

It’s a very anti-Steve Jobs thing to do, because of the return on invested capital is still higher than giving out a dividend, so that’s the big dilemma here. They’re getting pushed by outside investors to do it, and I hope that Tim Cook stays true to the culture of Apple.”

Brown had an interesting outlook on Apple Inc. (NASDAQ:AAPL) over the next six month period, mentioning that:

“When the new line of products and new refreshes come out–that has a better shot at being a driver, than whether or not the dividend is 2 or 3%. That is not what’s going to bring growth investors back into the stock, bidding it higher, expanding the multiple. There’s just no way.”

Of course, each investor is entitled to his or her own opinion, but it’s thoughts like these that likely draw the ire of many Cupertino-focused optimists operating on Main Street, thinking that a dividend hike will bring green returns to their portfolios.

Disclosure: none

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!